# ABF Tourette's Disorder Post Marketing Surveillance Study

> **NCT01795105** · — · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 692 (actual)

## Conditions studied

- Tourette's Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01795105
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-05-29
- **Final completion:** 2015-05-29
- **Target enrollment:** 692 (ACTUAL)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795105, "ABF Tourette's Disorder Post Marketing Surveillance Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01795105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*